ECASS III
2008
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
In 821 patients with acute ischaemic stroke 3–4.5 h from onset, alteplase improved mRS 0–1 at 90 days versus placebo.
Result
Efficacy: mRS 0–1 at 90 daysOR 1.34 (95% CI 1.02-1.76) · P = 0.04
Below 1 favours placebo, above 1 favours alteplase.
- Absolute difference
- 7.2 points
- NNT
- 14
Absolute difference and NNT are derived from the event rates.
Also reported: Symptomatic ICH 2.4% vs 0.2%.
- Subtopic
- IV thrombolysis
- Design
- Double-blind RCT
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Cited in
- AHA/ASA 2026 Stroke
- Source
- Hacke W, et al. N Engl J Med. 2008;359(13):1317-1329.doi 10.1056/NEJMoa0804656
Discussion & critique
Extended the thrombolysis window to 4.5 h, now standard.